Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinoma

Gut

Volumn 46, Issue 5, 2000, Pages 645-650

  Sarela, A I ^a   Macadam, R C A ^a   Farmery, S M ^a   Markham, A F ^a   Guillou, P J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Colorectal neoplasia; Messenger RNA; Polymerase chain reaction; Prognosis; Survival

Indexed keywords

MESSENGER RNA; SURVIVIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL DEATH; COLORECTAL CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

APOPTOSIS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0034021068     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.5.645     Document Type: Article

References (32)

1. 1 Kinzler KW, Vogelstein B. Lessons from hereditary colorectal carcinoma. Cell 1996;87:159-70.
2. 2 Bedi A, Pasricha PJ, Akhtar AJ, et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55:1811-16.
3. 3 Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994;73: 2013-26.
4. 4 Meterissian SH. Apoptosis: its role in the progression of and chemotherapy for carcinoma. J Am Coll Surg 1997;184: 658-66.
5. 5 Deschner EE. The relationship of proliferative defects to colorectal carcinoma. In: Beahrs OH, Higgins GA, Weinstein JJ, eds. Colorectal tumours. Philadelphia: JB Lippincott Company, 1986:81.
6. 6 Hockenberry DM, Zutter M, Hickey W, et al. Bcl-2 protein is topographically restricted in tissues characterised by apoptotic cell death. Proc Natl Acad Sci USA 1991;88: 6961-5.
7. 7 Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 1997;3:614-20.
8. 8 Hague A, Moorghen M, Hicks D, et al. BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene 1994;9:3367-70.
9. 9 Symonds H, Krall L, Remington L, et al. p53-dependent apoptosis suppresses tumour growth and progression in vivo. Cell 1994;78:703-11.
10. 10 Morin PJ, Vogelstein B, Kinzler KW. Apoptosis and APC in colorectal tumourigenesis. Proc Natl Acad Sci USA 1996;93:7950-4.
11. 11 Ambrosini G, Adida C, Altieri D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-21.
12. 12 Li F, Ambrosini G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998;396: 580-4.
13. 13 Kawasaki H, Altieri DC, Lu C-D, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 1998;58:5071-4.
14. 14 Lu C-D, Altieri DC, Tanigawa N. Expression of a novel anti-apoptosis gene, survivin, correlated with tumour cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res 1998;58:1808-12.
15. 15 Adida C, Berrcei D, Peuchmaur M, et al. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet 1998;351:882-3.
16. 16 Adida C, Crotty PL, McGrath J, et al. Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation. Am J Pathol 1998;152:43-9.
17. 17 Williams NS, Jass JR, Hardcastle JD. Clinicopathological assessment and staging of colorectal cancer. Br J Surg 1988;75:649-52
18. 18 Shibata DK. The polymerase chain reaction and the molecular genetic analysis of tissue biopsies. In: Herrington CS, McGee JO'D, eds. Diagnostic molecular pathology. A practical approach, vol II. Oxford: IRL Press, 1992:85-111.
19. 19 Nakamura M, Katano M, Fujimoto K, et al. A new prognostic strategy for gastric carcinoma. mRNA expression of tumor growth-related factors in endoscopic biopsy specimens. Ann Surg 1997;226:35-42
20. 20 Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumour cells. Cancer 1996;78:10-16.
21. 21 Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 1988;48:235-45.
22. 22 Garewal H, Bernstein H, Bernstein C, et al. Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer risk. Cancer Res 1996;56:1480-3.
23. 23 Granville DJ, Carthy CM, Hunt DWC, et al. Apoptosis: molecular aspects of cell death and disease. Lab Invest 1998;78:893-913.
24. 24 Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995;1: 149-53.
25. 25 Gryfe R, Swallow C, Bapat B, et al. Molecular biology of colorectal cancer. Curr Probl Cancer 1997;21:233-300.
26. 26 Diaz-Canton EA, Pazdur R. Adjuvant medical therapy for colorectal cancer. In: Saclarides TJ, ed. New and controversial issues in the management of colorectal cancer. Surg Clin North Am 1997;77:211-28.
27. 27 Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994;331:213-21.
28. 28 Shibata D, Reale M, Lavin P, et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996;335: 1727-32.
29. 29 Ahnen DJ, Feigl P, Quan G, et al. Ki-ras mutation and p53 overexpression predict the clinical behaviour of colorectal cancer: a southwest oncology group study. Cancer Res 1998;58:1149-58.
30. 30 Martinez-Lopez E, Abad A, Font A, et al. Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 1998;114:1180-7.
31. 31 Carethers JM, Hawn MT, Greenson JK, et al. Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 1998;114:1188-95.
32. 32 Chung DC. Molecular prognostic markers and colorectal cancer: the search goes on. Gastroenterology 1998;114: 1330-2.